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Background: Sepsis is one of the main causes of mortality and morbidity. The rapid detection of pathogens in
blood of septic patients is essential for adequate antimicrobial therapy and better prognosis. This study aimed to
accelerate the detection and discrimination of Gram-positive (GP) and Gram-negative (GN) bacteria and Candida
species in blood culture samples by molecular methods.
Methods: The Real-GPW, -GNW, and -CANW real-time PCR kit (M&D, Wonju, Republic of Korea) assays use the
TaqMan probes for detecting pan-GP, pan-GN, and pan-Candida species, respectively. The diagnostic performances
of the real-time PCR kits were evaluated with 115 clinical isolates, 256 positive and 200 negative blood culture
bottle samples, and the data were compared to results obtained from conventional blood culture.
Results: Eighty-seven reference strains and 115 clinical isolates were correctly identified with specific probes
corresponding to GP-bacteria, GN-bacteria and Candida, respectively. The overall sensitivity and specificity of the
real-time PCR kit with blood culture samples were 99.6% and 89.5%, respectively.
Conclusions: The Real-GPW, -GNW, and -CANW real-time PCR kits could be useful tools for the rapid and accurate
screening of bloodstream infections (BSIs).
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The incidence of sepsis in the United States is 240.4
cases per 100,000 people with an 8.7% annual increase
during the last several years [1]. The mortality rate of
sepsis ranges between 21% and 55%, and it has been
unchanged during the last decade [2,3].
Gram-positive (GP) bacteria are the most frequent
causative agents of bloodstream infections (BSIs) (30-50%
of all cases), followed by Gram-negative (GN) bacteria
in 25-30% and fungal infections representing 1-3% of
all sepsis cases [4]. Although rapid and accurate diagnosis
of sepsis plays an important role in the reduction of
mortality caused by sepsis, at least in 30% of sepsis cases,
the causative pathogen could not be detected [4]. Currently,* Correspondence: u931018@yonsei.ac.kr; hyelee@yonsei.ac.kr
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stated.blood culture is the standard method for the diagnosis of
bacteremia. However, the final results from identification/
antimicrobial susceptibility tests in the continuous monitor-
ing blood culture system (CMBCS) require at least 48 to
72 hrs [5]. Moreover, the CMBCS may cause false-negative
results when fastidious or slowly growing organisms are the
causative pathogens or when blood specimens are collected
after antimicrobial therapy has been started [6,7]. In order
to reduce the turnaround time for blood culture, a number
of molecular methods for rapid identification of pathogens
in positive blood culture samples have been tried, including
DNA microarrays [8], RNA-based fluorescence in situ
hybridization probes [9], and PCR-based assays like real-
time PCR [10,11]. Among these methods, PCR-based as-
says have been reported to provide an early and accurate
diagnosis of bacteremia and candidemia [12]. Sequence
analysis of the PCR product is time-consuming, but has
improved the rate of microbial detection. The sequence
of the 16S rRNA gene has been used to diagnose and
identify bacterial infection in clinical practice [13,14].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Wang et al. Annals of Clinical Microbiology and Antimicrobials 2014, 13:3 Page 2 of 10
http://www.ann-clinmicrob.com/content/13/1/3Some PCR-based assays could identify specific bacterial
pathogens [10,11], while broad range bacterial PCR can
detect almost any bacterial species [15,16]. Broad-range
bacterial PCR has a great advantage in that it is able to
detect microorganisms that are found less frequently, or
can even identify unknown causative agents of bacterial
origin.
However, conventional PCR is inconvenient for use in
routine rapid screening due to the time required for sample
handling and the risk of contamination in post-PCR ana-
lysis. Thus, it is necessary to develop a reliable broad-range
detection system for bacterial and fungal genomic DNA
from clinical samples that is fast, easy to use and covers a
wide range of clinically relevant microbes. Additionally,
the simultaneous quantification and differentiation of a
Gram stain in clinical blood samples with a broad-range
real-time PCR assay is rarely described.
In this study, we used a GP-bacteria, GN-bacteria and
Candida-specific TaqMan probe-based real-time PCR
system, which targets the bacterial 16S rRNA gene and
fungal 18S rRNA gene, allowing simultaneous detection
and discrimination of clinically-relevant GP-bacteria,
GN-bacteria and Candida species in a total of 87 reference
strains, 115 clinical isolates and 456 blood culture bottle
samples from BSI-suspected patients.
Materials and methods
Bacterial and fungal strains
In this study, to determine the specificity of the Real-
GP®, -GN®, and -CAN® real-time PCR kit (M&D, Wonju,
Republic of Korea), a total of 62 bacterial, 25 fungal refer-
ence strains (Table 1), and 115 clinical isolates from various
specimen types were used (Table 2). To evaluate the
performance of the Real-GP®, -GN®, and -CAN® real-
time PCR assay with blood culture bottle samples, a
total of 456 samples including 256 positive and 200
negative blood culture samples were collected. All bac-
terial strains and clinical specimens were collected
from December of 2011 to January of 2013 at Yonsei
University Wonju Severance Christian Hospital, Wonju,
Republic of Korea. All bacterial strains except Mycobacter-
ium spp. were grown on sheep blood agar and MacConkey
agar (BD Diagnostic System, Spark, MD, USA) at 37°C
overnight and identified by the microplate method [17],
the MicroScan® system (Siemens Healthcare Diagnostics,
Sacramento, CA, USA), and the Vitek 2 system (bioMérieux,
Durham, NC, USA). All mycobacterial reference strains
were grown on Lowenstein-Jensen media (Union Lab,
Seoul, Republic of Korea) at 37°C under 5% CO2 for 7
days to 8 weeks at Department of Microbiology, College
of Medicine, Yonsei University, Seoul, Republic of Korea.
All fungal reference strains were grown on Saboraud
dextrose agar (BD Diagnostic System, Spark, MD, USA)
at 25°C for several days at Korea Culture CollectionMedical Fungi (KCMF), Konyang University, Daejeon,
Republic of Korea.
Blood culture and collection of blood culture bottle samples
Three or two pairs of culture bottles for aerobes or anaer-
obes were incubated in the BacT/Alert 3D (bioMérieux)
and BACTEC® 9240 system (Becton Dickinson Diagnos-
tic System, Spark, MD, USA) or BACTEC FX (Becton
Dickinson) blood culture systems for 5 days after inocu-
lating blood drawn from the patient at the bedside. If no
bacterial growth was detected within 5 days, the blood
culture was considered negative. When bacterial growth
was noted, the culture sample was inoculated into blood
and MacConkey agar plates (BD Diagnostic Systems,
Sparks, MD, USA), and then cultured overnight at 37°C
in a 5% CO2 incubator. Isolates were identified based on
the colony morphology, Gram stain, biochemical tests,
and commercial identification kits. MicroScan® (Siemens
Healthcare Diagnostics, Sacramento, CA, USA) overnight
Pos BP Combo 28, MICroSTREP Plus, overnight Neg
Combo 53, and Neg Combo 54 panels were used for
the identification of GP, streptococci, and GN bacteria. For
identification of Candida spp., a VITEK-2 (bioMérieux,
Marcy l’Etoile, France) YST ID CARD was used.
DNA preparation
To prepare DNA templates for the real-time PCR TaqMan
assay, one colony of each strain and clinical isolate was
suspended in 100 μL of DNA extraction solution (M&D,
Wonju, Republic of Korea). The suspended bacterial solution
was boiled for 10 min. After centrifugation at 13,000 g for
10 min, the supernatant was used for DNA templates.
For preparation of DNA template from the blood culture
bottle samples, 0.5 mL of blood suspension were taken
directly from the blood culture bottle, and 1 mL of
phosphate-buffered saline (pH 8.0) was added and centri-
fuged at 13,000 g for 1 min. The supernatant was removed,
and the pellet was resuspended in 1 mL of ACK solution
(0.15 M of NH4Cl, 1 mM of KHCO3, and 0.1 mM of
Na2EDTA), and centrifuged at 13,000 g for 1 min. This
washing step was repeated twice, and the pellet was
resuspended in DNA extraction solution as described
above for the clinical isolates.
Real-time PCR TaqMan assay
The real-time PCR TaqMan assay was carried out with
the Real-GP®, -GN® and -CAN® real-time PCR assay kits
(M&D), and a CFX-96 real-time PCR system (Bio-rad,
Hercules, CA, USA) and an ABI 7500 FAST instrument
(Applied Biosystem, Foster City, CA, USA) were used for
the thermo-cycling and fluorescence detection. These
real-time PCR assay kits are only able to determine GP
bacteria, GN bacteria, and Candida, respectively for rapid
screening of BSIs however they do not allow species or
Table 1 The specificity of Real-GP®, -GN®, and -CAN®















Staphylococcus S. aureus 29213 26.59 UD UD
S. aureus 25923 28.42 UD UD
S. xylosus 29971 20.81 UD UD
Enterococcus E. hirae 9790 26.31 UD UD
E. raffinosus 49427 28.09 UD UD
E. sulfureus 49903 28.40 UD UD
E. durans 19432 23.48 UD UD
E. casseliflavus 700327 25.98 UD UD
E. faecium 19434 26.72 UD UD
E. faecalis 29212 25.33 UD UD
E. mundtii 43186 29.90 UD UD
E. cecorum 43198 21.68 UD UD
E. flavescens 49997 22.21 UD UD
E. gallinarum 49573 23.88 UD UD
E. faecalis 51299 24.10 UD UD
E. solitarius 49428 30.44 UD UD
E. faecium 35667 24.66 UD UD
E. malodoratus 43197 27.02 UD UD
E. saccharolyticus 43076 23.06 UD UD
E. casseliflavus 25788 26.28 UD UD
Streptococcus S. pneumoniae 49619 21.11 UD UD
S. agalactiae 13813 26.41 UD UD
Micrococcus M. luteus 49732 22.36 UD UD
Mycobacterium M. avium 25291 23.06 UD UD
M. chelonae 35749 21.34 UD UD
M. gastri 15754 23.90 UD UD
M. kansasii 12478 22.17 UD UD
M. nonchromogenicum 19530 18.31 UD UD
M. phlei 11758 25.09 UD UD
M. smegmatis 19420 24.40 UD UD
M. triviale 23292 22.66 UD UD
M. aurum 23366 24.83 UD UD
M. farcinogen 35753 20.00 UD UD
M. gilvum 43909 19.40 UD UD
M. neoaurum 25795 17.83 UD UD
M. parafortuitum 19686 19.06 UD UD
M. peregrinum 14467 18.57 UD UD
Table 1 The specificity of Real-GP®, -GN®, and -CAN®
real-time PCR assays for 62 bacterial and 25 fungal
reference strains (Continued)
M. septicum 700731 23.47 UD UD




Escherichia E. coli 25922 UD 20.46 UD
E. coli 35218 UD 17.90 UD
Enterobacter E. aerogenes 1304 UD 19.09 UD
Citrobacter C. freundii 6750 UD 14.19 UD
Shigella S. boydii DML 399 UD 25.59 UD
S. dysenteriae DML 400 UD 18.38 UD
S. flexneri 9199 UD 21.82 UD
Serratia S. liquifaciens 27952 UD 24.96 UD
Salmonella S. typhi 19430 UD 16.54 UD
S. enteritidis 13076 UD 20.15 UD
S. paratyphi 11511 UD 19.61 UD
S. typhimurium 13311 UD 16.19 UD
S. newport 6962 UD 17.22 UD
Klebsiella K. pneumoniae 13883 UD 20.60 UD
K. oxytoca 700324 UD 21.87 UD
Proteus P. alcalifaciens 51902 UD 18.38 UD
P. vulgaris 49132 UD 17.13 UD
P. mirabilis 49132 UD 16.34 UD
Pseudomonas P. cepacia 25608 UD 19.66 UD
P. aeruginosa 27853 UD 16.57 UD
Haemophilus H. influenzae 49247 UD 18.61 UD
Leclercia L. adecarboxylata 23216 UD 15.70 UD
Bordetella B. bronchiseptica 10580 UD 19.44 UD
Fungi




Aspergillus A. oryzae var oryzae KACC
44847
UD UD UD
A. oryzae var. effusus 1010 UD UD UD










A. tamari 20054 UD UD UD
Fusarium F. acuminatum 10466 UD UD UD
Aureobasidium A. pullulans KACC
41291
UD UD UD
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Table 1 The specificity of Real-GP®, -GN®, and -CAN®
real-time PCR assays for 62 bacterial and 25 fungal
reference strains (Continued)
Bipolaris B. sorokiniana KACC
44841
UD UD UD
Cryptococcus C. neoformans KCMF
20047
UD UD UD
Kodamea K. ohmeri KCMF
20430
UD UD UD
Saccaromyces S. cerevisiae KCMF
50427
UD UD UD






Microsporum M. canis KCMF
10531
UD UD UD
Epidermophyton E. floccosum 52063 UD UD UD
Malassezia M. furfur KCMF
20409
UD UD UD
Candida C. albicans 36802 UD UD 26.42
C. tropicalis 14506 UD UD 25.98
C. glabrata 38326 UD UD 17.09
C. parapsilosis 7330 UD UD 24.27
C. krusei 20298 UD UD 19.67
Abbreviations: ATCC American type culture collection, DML Diagnostic
Microbiology Laboratory, Biomedical laboratory science, Yonsei University;
KACC Korean Agricultural Culture Collection; KCMF Korea Culture Collection
Medical Fungi; UD Undetermined.
Table 2 Real-GP®, -GN®, and -CAN® real-time PCR assay re-
sults for discriminating the Gram-positive and -negative












Staphylococcus aureus 12 GP 22.44-26.65 24.47
Staphylococcus
spp. (CoNS)
8 GP 19.46-28.71 21.5
Streptococcus spp. 5 GP 17.35-30.46 24.25
Enterococcus faecalis 4 GP 25.2-27.3 26.37
Enterococcus faecium 10 GP 21.3-31.6 26.58
Enterococcus mundtii 1 GP 27.85 27.85
Corynebacterium spp. 1 GP 24.51 24.51
Escherichia coli 16 GN 12.68-30.65 23.26
Klebsiella pneumoniae 13 GN 15.48-26.08 20.73
Pseudomonas
aeruginosa
13 GN 15.23-19.96 18.11
Acinetobacter
baumannii
11 GN 18.09-24.65 21.04
Enterobacter asburiae 2 GN 15.79 15.79
Enterocobacter cloacae 1 GN 15.41 15.41
Moraxella catarrhalis 1 GN 33.54 33.54
Serratia marcescens 1 GN 21.64 21.64
Providencia rettgeri 1 GN 24.3 24.30
Morganella morganii 1 GN 20.6 20.60
Proteus mirabilis 1 GN 24.88 24.88
Aeromonas spp. 1 GN 25.97 25.97
Citrobacter fruendii 2 GN 17.11-18.01 17.56
Candida albicans 5 CAN 17.61-29.56 23.9
Candida parapsilosis 3 CAN 24.73-30.95 27.58
Candida tropicalis 1 CAN 26.62 26.62
Candida glabrata 1 CAN 17.68 17.68
Total 115
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real-time PCR amplification was performed in a total vol-
ume of 25 μL that contained 12.5 μL of 2 × Thunderbird
probe qPCR mix (Toyobo, Osaka, Japan), 5 μL of primer
and TaqMan probe mixture, 5 μL of template DNA, and
ddH2O was added to give a final volume of 25 μL for each
sample.
Positive and negative controls were included throughout
the procedure. No-template controls with ddH2O instead
of template DNA were incorporated in each run under
the following conditions: 95°C for 3 min and 40 cycles of
95°C for 20 s and 60°C for 40 s in single real-time PCR.
The bacterial load was quantified by determining the cycle
threshold (CT), the number of PCR cycles required for the
fluorescence to exceed a value significantly higher than
the background fluorescence.
Results
Sensitivity and specificity of the Real-GP®, -GN®, and -CAN®
real-time PCR TaqMan assay with reference bacterial and
fungal strains
The detection limit of the real-time PCR TaqMan assay
for GP-, GN-bacteria, and Candida was 103 CFU/mL,
103 CFU/mL, and 104 CFU/mL, respectively. The CTvalues for GP-, GN-bacteria, and Candida with each cell
concentrate (108 - 102 CFU/mL) ranged from 16.17 to
32.46, 15.06 to 29.03, and 17.68 to 32.47, respectively
(Figure 1).
All DNA extractions of bacterial and fungal reference
strains showed the positive fluorescence signals with
real-time PCR TaqMan assay. The CT values for GP-,
GN-bacteria and Candida real-time PCR assays ranged
from 17.83 to 30.44, 14.19 to 25.59, and 17.09 to 26.42,
respectively (Table 1).
Results of Real-GP®, -GN®, and -CAN® real-time PCR
TaqMan assay with clinical isolates
The results between subculture and real-time PCR assay













Figure 1 Detection limits of the three target probes from 10-fold serial diluted spiked samples. Serially diluted DNA amounts ranging
from 108 to 10° CFU/mL were used to determine the detection limit of the multiplex real-time PCR assay. (A) amplification curve of GP-bacteria
probe using Staphylococcus aureus, (B) amplification curve of GN-bacteria probe using Escherichia coli, (C) amplification curve of Candida probe
using Candida glabrata. The overall detection limit of this assay for GP-, GN-bacteria, and Candida probe was approximately 103 to 104 CFU/mL.
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coccus aureus, 10 Enterococcus faecium, 8 coagulase-nega-
tive staphylococci (CoNS), 5 Streptococcus spp., 4 E. faecalis,
1 Enterococcus mundtii, and 1 Corynebacterium spp.,
were positive by Real-GP® assay and sixty-four GN clinical
isolates, which included 16 Escherichia. coli, 13 Klebsiella
pneumoniae, 13 Pseudomonas aeruginosa, 11 Acinetobacter
baumannii, two Citrobacter fruendii, two Enterobacter
asburiae, one Enterobacter coloacae, one Aeromonas spp.,
one Moraxella catarrhalis, one Morganella morganii, one
Proteus mirabilis, one Providencia rettgeri, and one Serratia
marcescens, were positive by Real-GN® assay. Ten Candida
spp. clinical isolates, which included five C. albicans, threeC. parapsilosis, one C. tropicalis and one C. glabrata, were
positive by Real-CAN® assay (Table 2). The CT values of
clinical isolates of GP, GN, and Candida species ranged
from 17.35 to 31.60, 12.68 to 33.54, and 17.61 to 30.95,
respectively.
Results of Real-GP®, -GN®, and -CAN® real-time PCR
TaqMan assay with positive and negative blood culture
bottle samples
Of 256 positive blood culture bottles, GP-bacteria, GN-
bacteria, and Candida were detected in 175, 70, and four
bottles, respectively. Two kinds of microorganisms were
detected from six bottles. Among 175 GP-bacteria-positive
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prevalent at 26.7% (n = 47), followed by S. aureus (n = 24),
Staphylococcus hominis (n = 17), GP rods (n = 16), and
Staphylococcus capitis (n = 14). One S. hominis showed a
negative result with real-time PCR. The CT values of 175
GP-bacteria ranged from 11.52 to 34.39. Seventy GN-
bacteria from blood cultures included Escherichia coli
(50%, n = 35), Klebsiella pneumoniae (n = 13), Acinetobacter
baumannii (n = 5), and Pseudomonas aeruginosa (n = 3).
The CT values of the 70 GN-bacteria ranged from 6.56 to
24.08. A total of four Candida-positive samples included
two C. albicans, one C. parapsilosis and one C. tropicalis
(Table 3). The CT values of the four Candida species
ranged from 22.81 to 31.98.
Among six cases of polymicrobial bacteremia, three were
concordant between the standard identification method
and real-time PCR assay, but the other three cases showed
positive results for only a single organism by real-time
PCR assay (Table 3).
Of 200 negative blood culture bottle samples, 21 samples
(10.5%), including seven GP- and 14 GN-bacteria, had
positive results with the real-time PCR assay (Table 3). The
CT values of 7 GP-bacteria and 14 GN-bacteria ranged
from 17.54 to 23.28, and 17.79 to 31.26, respectively.
The sensitivity of the real-time PCR kit for GP, GN,
Candida and polymicrobial isolates was 99.4%, 100%,
100% and 100%, respectively, and the specificity of the
real-time PCR kit for GP, GN and Candida was 96.5%,
93.0% and 100%, respectively. Therefore, the overall
sensitivity and specificity of the real-time PCR kit com-
pared with blood culture method were 99.6% and 89.5%,
respectively.
Discussion
Blood culture is the current gold standard method for
detecting BSI microbial pathogens; although it allows
microbes to be identified and their susceptibility profiles
to be tested, the method has several limitations. Lack of
rapidity is a major problem because detection of bacterial
and fungal growth requires approximately 12 to 48 hr, and
it can take more time in the case of fastidious bacterial or
invasive fungal infection [18,19].
Currently, novel diagnostic technique such as MALDI-
TOF MS was developed and evaluated with positive blood
culture bottle samples [20,21]. It could provide species or
genus identification more rapidly for detecting BSIs
than current molecular assays however it cannot replace
to routine laboratory workflow in current clinical setting
yet because of the cost, facility, and examiner. Current
DNA-based Gram identification methods include Gram
stain-specific PCR [22], nested PCR [23], and PCR probe
hybridization [24-26], but all of these methods contain at
least two sequential steps, and therefore they require a
longer turnaround time to get a final result. For instance,the conventional PCR assays incorporate a pair of oligo-
nucleotide primers to amplify a specific target gene that is
then detected using agarose gel electrophoresis combined
with an intercalating dye (e.g., ethidium bromide, EtBr)
and UV light. The real-time PCR TaqMan assay is a
promising tool for detecting bacterial genomic DNA
from biological fluids (direct clinical specimens) such as
blood, urine and sputum. Fluorescence hybridization
probes result in fast detection of small amounts of bacter-
ial genomic DNA and correct Gram classification [27]. It
is not only applicable from one sample to a number of
samples at once but also it can be commonly used for
diagnostic purpose in current clinical laboratories cost
effectively.
In this study, Real-GP®, -GN® and -CAN® real-time PCR
TaqMan assays, which target the bacterial 16S rRNA and
fungal 18S rRNA, were evaluated with reference bacterial
and fungal strains, clinical isolates, and direct blood cul-
ture bottle samples. The results showed that the real-time
PCR TaqMan assay was rapid; it usually took no more
than 4 hr to complete the whole experiment, which
included only 1 hr of sample preparation and 1.5 hr for
DNA amplification, because thermal cycling is much
faster and amplicon detection is performed in real time.
It allowed for the rapid quantification and Gram classifi-
cation of bacteria and fungi without the post-PCR
process. Furthermore, it was very specific because the
results were completely accurate when compared with
the standard blood culture method.
In previous reports from other study groups, CoNS
were reported to be the major causative microorganisms in
sepsis [28,29]. In this study, S. epidermidis was identified as
the most common in positive blood culture bottle samples,
with a total of 47 cases, which is identical to the results
from other studies. Therefore, future study of the role and
the effect of S. epidermidis infection in the bloodstream
might be essential in the Korean population. All GN-
bacteria and Candida samples were positive and all
GP-bacteria samples, except for one sample, were positive
based on real-time PCR assay in clinical isolates and posi-
tive blood culture samples. Therefore, the sensitivity was
sufficient for performance with positive blood culture bottle
samples. Also, candidiasis is a yeast infection caused by
different Candida species and can cause opportunistic
infections of the skin and mucosa as well invasive infec-
tions. Candidiasis accounts for up to 10% of bloodstream
infections and is associated with an exceptionally high
mortality rate [30]. Invasive fungal infections are in-
creasingly recognized as a primary cause of morbidity
and mortality especially in immunocompromised patients.
To reduce mortality in patients with invasive candidiasis,
early diagnosis and rapid initiation of antifungal therapy is
very important for the survival of patients. However, our
research has shown that the test was just 4/256 (1.6%) in
Table 3 Comparison of the results of Real-GP®, -GN®, and -CAN® real-time PCR assay and BACTEC 9240 for detection of
bloodstream infection in positive and negative blood culture bottle samples
Blood culture result
Real-time PCR TaqMan assay (n) GP GN CAN
Positive Negative (CT range) (CT range) (CT range)
Blood culture positive (n = 256) 255 1
Gram-positive bacteria (n = 176) 175 1
Staphylococccus epidermidis (47) 47 0 13.08-33.99 UD UD
S. aureus (24) 24 0 13.24-34.19 UD UD
S. hominis (17) 16 1 13.69-30.00 UD UD
S. capitis (14) 14 0 13.60-25.10 UD UD
S. haemolyticus (8) 8 0 14.68-33.30 UD UD
S. warneri (1) 1 0 18.50 UD UD
S. saprophyticus (1) 1 0 16.57 UD UD
S. xylosus (1) 1 0 21.23 UD UD
S. chleiferi (1) 1 0 20.44 UD UD
Streptococcus salivarius (5) 5 0 13.55-23.58 UD UD
S. mitis (4) 4 0 11.52-23.12 UD UD
S. pneumoniae (4) 4 0 16.37-17.77 UD UD
S. agalactiae (2) 2 0 21.52-25.95 UD UD
S. pyogenes (1) 1 0 22.10 UD UD
S. dysgalactiae (1) 1 0 15.81 UD UD
S. parasangus (1) 1 0 12.96 UD UD
Streptococcus spp. (2) 2 0 17.87-24.89 UD UD
Enterococcus faecium (8) 8 0 26.43-27.54 UD UD
E. faecalis (1) 1 0 14.50 UD UD
Micrococcus spp. (5) 5 0 20.96-31.33 UD UD
Propionibacterium acnes (3) 3 0 23.77-26.86 UD UD
Peptostreptococcus asaccharolyticus (1) 1 0 26.72 UD UD
Peptostreptococcus micros (1) 1 0 26.00 UD UD
Corynebacterium spp. (6) 6 0 26.47 UD UD
Gram positive rods (16) 16 0 12.43-34.39 UD UD
Gram-negative bacteria (n = 70) 70 0
Escherichia coli (35) 35 0 UD 9.86-21.89 UD
Klebsiella pneumoniae (13) 13 0 UD 12.84-13.20 UD
Acinetobacter baumannii (5) 5 0 UD 10.53-11.89 UD
A. woffii (1) 1 0 UD 12.22-15.11 UD
Enterobacter spp. (2) 2 0 UD 6.56 UD
Pseudomonas aeruginosa (3) 3 0 UD 12.08 UD
Salmonella group D (1) 1 0 UD 13.62-21.48 UD
Proteus mirabilis (1) 1 0 UD 14.38 UD
Aeromonas spp. (2) 2 0 UD 20.10 UD
Morganella morganii (1) 1 0 UD 10.39 UD
Haemophillus influenzae (1) 1 0 UD 20.68 UD
Chryseobacterium indologenes (1) 1 0 UD 14.40 UD
Sphingomonas paucimobilis (1) 1 0 UD 24.08 UD
Serratia marcescens (1) 1 0 UD 9.48 UD
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Table 3 Comparison of the results of Real-GP®, -GN®, and -CAN® real-time PCR assay and BACTEC 9240 for detection of
bloodstream infection in positive and negative blood culture bottle samples (Continued)
Citrobacter freundii (1) 1 0 UD 14.24 UD
Candida species (n = 4) 4 0
Candida albicans (2) 2 0 UD UD 26.98-31.52
C. parapsilosis (1) 1 0 UD UD 31.98
C. tropicalis (1) 1 0 UD UD 22.81
*Polymicrobial infection (n = 6) 6 0
Streptococcus agalactiae, Citrobacter koseri (1) 1 - 14.61 10.61 UD
Enterococcus faecium, Candida albicans (1) 1 - 17.18 UD 29.51
Enterococcus faecalis, Proteus mirabilis (1) 1 - UD 12.14 UD
Escherichia coli, Enterococcus gallinarym (1) 1 - UD 13.25 UD
Klebsiella pneumonia, Enterococcus casseliflavus (1) 1 - UD 13.31 UD
Klebsiella pneumonia, Enterobacter cloacae (1) 1 - UD 14.42 UD
Blood culture negative (n = 200) 21 179
Gram-positive bacteria 7 193 17.54-27.43 - -
Gram-negative bacteria 14 186 - 20.48-31.26 -
Candida species 0 200 - - -
*GP-, GN-bacteria or fungi mixed infection.
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more tests with larger number of samples. The positivity
of the Real-GP®, -GN®, -CAN® real-time PCR assay (21/200;
10.5%) was significantly higher than that of blood culture
(0/200; 0%). When blood culture was used as a standard
control, the sensitivity of real-time PCR was 100% and the
specificity was 89.5% (Table 4). The gold standard for
diagnosing sepsis is now still blood culture, even though,
in many cases, blood cultures are negative in the faceTable 4 The sensitivity and specificity of the Real-GP®, -GN®,
and -CAN® real-time PCR assay with positive and negative
blood culture bottle samples
Blood culture
Real-time PCR
Sensitivity SpecificityTaqMan assay (n)
Positive Negative
Blood culture
positive (n = 256)
255 1 99.6% -
Gram-positive
bacteria (176)
175 1 99.4% -
Gram-negative
bacteria (70)
70 0 100% -
Candida species (4) 4 0 100% -
Multiple infection (6) 6 0 100% -
Blood culture
negative (n = 200)
21 179 - 89.5%
Gram-positive bacteria 7 193 - 96.5%
Gram-negative bacteria 14 186 - 93.0%
Candida species 0 200 - 100%of strong clinical indicators of sepsis [31]. Therefore,
to effectively evaluate the real-time PCR kit for rapid
screening of BSI, further evaluation is required with
direct blood samples or a larger number of negative blood
culture bottle samples from patients who are suspected to
have sepsis.
Polymicrobial culture data show that six samples were
infected with two microorganisms each. Among these six
cases, the results of three were consistent between
conventional culture and real-time PCR assay (showed
double signal), however, three samples showed just a
single positive signal with real-time PCR, even though
two microorganisms were identified by the culture
method. According to the real-time PCR results, GN
signals were positive and GP signals were undetermined
in those three samples. The reason might be due to the
fact that the GP-bacteria, Enterococcus spp., grow more
slowly, and thus, the number of GP-bacteria is much fewer
than that of GN bacteria (E. coli and K. pneumoniae) in
blood culture bottle samples, and the fluorescence signal
for GN could not be detected.
Conclusions
The use of the molecular diagnostic assay, real-time PCR
TaqMan assay, is more effective for rapid screening of BSI
than microbiological diagnosis. In this study, this technique
allowed the simultaneous detection, quantification, and
Gram identification of bacterial and fungal organisms dir-
ectly from blood culture bottle samples. Even culture, spe-
cies or genus identification, and antimicrobial susceptibility
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TaqMan assay, it could not only differentiate bacterial and
fungal from viral and other pathogens, but it could also
classify Gram staining with a much shorter turnaround
time than the gold standard culture method.
The Real-GP®, -GN®, and -CAN® real-time PCR assays
may provide essential information to accelerate therapeutic
decisions for earlier and adequate antibiotic treatment in
the acute phase of sepsis.
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